NHS access to semaglutide for weight management (Wegovy) is restricted to specialist services for patients with BMI 35 kg/m (or 32.5 kg/m for certain ethnic backgrounds) plus weight-related comorbidities
It can increase the effects of insulin and certain oral hypoglycemic drugs, leading to low blood sugar levels
Executives said the biggest concern is prescription growth appears to have plateaued after the first month surge, though in a new category, prescriptions tend to rise sharply for the first several months
Researchers from the University of Oxford, University of Dundee, University of Copenhagen, University of British Columbia, Churchill Hospital, Newcastle University, University of Bath, and University of Exeter also contributed to the study
Some other foods may be fortified with it
Allergy 3, 279290